Literature DB >> 28698663

Medical devices for the treatment of obesity.

Phong Ching Lee1, John Dixon2.   

Abstract

Obesity is a major public health concern that leads to numerous metabolic, mechanical and psychological complications. Although lifestyle interventions are the cornerstone of obesity management, subsequent physiological neurohormonal adaptations limit weight loss, strongly favour weight regain and counteract sustained weight loss. A range of effective therapies are therefore needed to manage this chronic relapsing disease. Bariatric surgery delivers substantial, durable weight loss but limited access to care, perceived high risks and costs restrict uptake. Medical devices are uniquely positioned to bridge the gap between more conservative lifestyle intervention and weight-loss pharmacotherapy and more disruptive bariatric surgery. In this Review, we examine the range of gastrointestinal medical devices that are available in clinical practice to treat obesity, as well as those that are in advanced stages of development. We focus on the mechanisms of action as well as the efficacy and safety profiles of these devices. Many of these devices are placed endoscopically, which provides gastroenterologists with exciting opportunities for treatment.

Entities:  

Mesh:

Year:  2017        PMID: 28698663     DOI: 10.1038/nrgastro.2017.80

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN: 1759-5045            Impact factor:   46.802


  121 in total

1.  Closed-loop gastric electrical stimulation versus laparoscopic adjustable gastric band for the treatment of obesity: a randomized 12-month multicenter study.

Authors:  T Horbach; G Meyer; S Morales-Conde; I Alarcón; F Favretti; M Anselmino; G M Rovera; J Dargent; C Stroh; M Susewind; A J Torres
Journal:  Int J Obes (Lond)       Date:  2016-09-16       Impact factor: 5.095

Review 2.  Neuroendocrine adaptations to bariatric surgery.

Authors:  J B Dixon; E A Lambert; G W Lambert
Journal:  Mol Cell Endocrinol       Date:  2015-06-01       Impact factor: 4.102

3.  The effect of the endoscopic duodenal-jejunal bypass liner on obesity and type 2 diabetes mellitus, a multicenter randomized controlled trial.

Authors:  Parviez Koehestanie; Charlotte de Jonge; Frits J Berends; Ignace M Janssen; Nicole D Bouvy; Jan Willem M Greve
Journal:  Ann Surg       Date:  2014-12       Impact factor: 12.969

4.  Human experience with an endoluminal, endoscopic, gastrojejunal bypass sleeve.

Authors:  Bryan J Sandler; Roberto Rumbaut; C Paul Swain; Gustavo Torres; Luis Morales; Lizcelly Gonzales; Sarah Schultz; Mark Talamini; Santiago Horgan
Journal:  Surg Endosc       Date:  2011-04-13       Impact factor: 4.584

5.  BioEnterics Intragastric Balloon: The Italian Experience with 2,515 Patients.

Authors:  A Genco; T Bruni; S B Doldi; P Forestieri; M Marino; L Busetto; C Giardiello; L Angrisani; L Pecchioli; P Stornelli; F Puglisi; M Alkilani; A Nigri; N Di Lorenzo; F Furbetta; A Cascardo; M Cipriano; M Lorenzo; N Basso
Journal:  Obes Surg       Date:  2005-09       Impact factor: 4.129

6.  Implantable gastric stimulation for the treatment of clinically severe obesity: results of the SHAPE trial.

Authors:  Scott A Shikora; Richard Bergenstal; Marc Bessler; Fred Brody; Gary Foster; Arthur Frank; Mark Gold; Samuel Klein; Robert Kushner; David B Sarwer
Journal:  Surg Obes Relat Dis       Date:  2008-10-01       Impact factor: 4.734

7.  Perceived barriers to bariatric surgery among morbidly obese patients.

Authors:  Bianca B Afonso; Raul Rosenthal; Ka Ming Li; Jorge Zapatier; Samuel Szomstein
Journal:  Surg Obes Relat Dis       Date:  2009-10-03       Impact factor: 4.734

8.  Intra-abdominal vagal blocking (VBLOC therapy): clinical results with a new implantable medical device.

Authors:  M Camilleri; J Toouli; M F Herrera; B Kulseng; L Kow; J P Pantoja; R Marvik; G Johnsen; C J Billington; F G Moody; M B Knudson; K S Tweden; M Vollmer; R R Wilson; M Anvari
Journal:  Surgery       Date:  2008-05-09       Impact factor: 3.982

Review 9.  Changes in comorbidities and improvements in quality of life after LAP-BAND placement.

Authors:  John B Dixon; Paul E O'Brien
Journal:  Am J Surg       Date:  2002-12       Impact factor: 2.565

Review 10.  Novel Endoscopic Management of Obesity.

Authors:  Jerome Dargent
Journal:  Clin Endosc       Date:  2016-01-28
View more
  6 in total

Review 1.  Obesity: Pathophysiology and Management.

Authors:  Kishore M Gadde; Corby K Martin; Hans-Rudolf Berthoud; Steven B Heymsfield
Journal:  J Am Coll Cardiol       Date:  2018-01-02       Impact factor: 24.094

2.  A Novel Intragastric Satiety-Inducing Device to Inhibit Weight Gain in Juvenile Pigs: a Pilot Study.

Authors:  Nader Bakheet; Hee Kyong Na; Jung-Hoon Park; Dae Sung Ryu; Jae Yong Jeon; Mouen A Khashab; Vivek Kumbhari; Jiaywei Tsauo; Ho-Young Song; Hong Tao Hu; Do Hoon Kim; Hwoon-Yong Jung
Journal:  Obes Surg       Date:  2020-09-04       Impact factor: 4.129

Review 3.  Endoscopic bariatrics: current therapies and future directions.

Authors:  Debashis Reja; Clark Zhang; Avik Sarkar
Journal:  Transl Gastroenterol Hepatol       Date:  2022-04-25

4.  IFSO Worldwide Survey 2016: Primary, Endoluminal, and Revisional Procedures.

Authors:  Luigi Angrisani; A Santonicola; P Iovino; A Vitiello; K Higa; J Himpens; H Buchwald; N Scopinaro
Journal:  Obes Surg       Date:  2018-12       Impact factor: 4.129

Review 5.  Bile reflux after one anastomosis gastric bypass surgery: A review study.

Authors:  Behrouz Keleidari; Mohsen Mahmoudieh Dehkordi; Masoud Sayadi Shahraki; Zeinab Sadat Ahmadi; Mahmoud Heidari; Abbas Hajian; Hossein Taheri Nasaj
Journal:  Ann Med Surg (Lond)       Date:  2021-03-26

Review 6.  The ups and downs of caloric restriction and fasting: from molecular effects to clinical application.

Authors:  Sebastian J Hofer; Didac Carmona-Gutierrez; Melanie I Mueller; Frank Madeo
Journal:  EMBO Mol Med       Date:  2021-11-15       Impact factor: 12.137

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.